Med-Tech Innovation September 6, 2024

For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.

Developed by Samphire Neuroscience, a neurotechnology company based in London, this device leverages recent findings that show hormonal fluctuations during the menstrual cycle can alter brain activity, structure, and function. By harnessing the brain-cycle connection, Samphire has adapted a technique once limited to specialised clinics into an at-home wearable device that goes by the name Nettle.

This approach reprogrammes how the brain perceives symptoms and offers a medically certified and clinically tested solution that outperforms traditional treatments.

The impact of menstrual symptoms on quality of life

Over 90% of females of...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
Phillips launches updated AI tech for MRI scanners
Medtronic partners with Brainomix on AI stroke tool
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Share This Article